Quarterly report pursuant to Section 13 or 15(d)

Company Description and Summary of Significant Accounting Policies, Nature of Business (Details)

v3.24.2.u1
Company Description and Summary of Significant Accounting Policies, Nature of Business (Details)
6 Months Ended
Jun. 30, 2024
Product
Nature of Business [Abstract]  
Number of FDA approved product 1